| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |